Mettler-Toledo International, Inc. $MTD Holdings Raised by Barclays PLC

Barclays PLC increased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 3.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 272,696 shares of the medical instruments supplier’s stock after purchasing an additional 9,568 shares during the quarter. Barclays PLC owned 1.32% of Mettler-Toledo International worth $334,764,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc lifted its position in shares of Mettler-Toledo International by 42.1% in the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 8 shares during the last quarter. SJS Investment Consulting Inc. grew its position in shares of Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares during the last quarter. Salomon & Ludwin LLC acquired a new stake in Mettler-Toledo International during the third quarter worth about $43,000. Root Financial Partners LLC bought a new position in Mettler-Toledo International in the third quarter worth about $42,000. Finally, MV Capital Management Inc. boosted its stake in Mettler-Toledo International by 50.0% in the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 12 shares during the period. Institutional investors own 95.07% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,456,714.56. This trade represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Trading Down 3.9%

Shares of NYSE:MTD opened at $1,211.65 on Friday. The company has a 50 day moving average of $1,398.26 and a 200-day moving average of $1,371.25. The firm has a market cap of $24.63 billion, a P/E ratio of 28.77, a P/E/G ratio of 2.65 and a beta of 1.43. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping the consensus estimate of $12.76 by $0.60. The firm had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $12.41 earnings per share. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Equities research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on MTD. Citigroup raised their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 target price on the stock. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Finally, Barclays lowered their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and a consensus price target of $1,435.42.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.